Home  »  Companies   »  Johnson & Johnson (JNJ) Stock: Forecast and P...

Johnson & Johnson (JNJ) Stock: Forecast and Prospect

Related Topics

UBS lowered the price target for the Johnson & Johnson (NYSE:JNJ) stock from “a Buy” to “a Neutral”. The rating was released on April 28, 2020. We previously noted in another research note published on April 22, 2020 by BofA/Merrill that upgraded the stock from a Neutral to a Buy with a price target of $175 for JNJ stock. The research report from Citigroup has initiated the stock to Buy, with a price target set at $163. The stock was upgraded by Barclays, who disclosed in a research note on December 19, 2019, from Equal Weight to Overweight and set the price objective to $173. In their research brief published December 17, 2019, Morgan Stanley analysts upgraded the Johnson & Johnson stock from Equal-Weight to Overweight with a price target of $170.


5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored



Historical Earnings Surprises and Revenue Forecasts

Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock price to increase when earnings exceed market expectations and progressively decrease when earnings do not meet expectations. The firm reported an earnings per share (EPS) of $2.59 during the last quarter as opposed to a consensus estimate of $2.34, which indicates the company beat its estimate by $0.25, which implies that the company surprised the market by 10.70%. It appears that the average earnings per share estimate for the current quarter (ending in Jun 2021) is $2.26. This is an average of 11 analysts’ earnings, where the high earnings per share estimate is $2.43 and the low earnings per share estimate is $2.17. According to 9 analyst estimates, an average revenue estimate of $22.17B is projected for the current quarter with a high revenue estimate of $22.58B and a low estimate of $21.76B.

The latest trade, Performances and Moving Averages give us the following Picture

The share price of Johnson & Johnson (NYSE:JNJ) dipped -0.57% to close Tuesday’s market session at $163.18, lower as compared to yesterday’s close. The stock price fluctuated between $162.47 and $163.91 throughout the trading session with the volume trading being 6175572 shares, which represented a significant variation when compared to the three months average volume of 8.10 million shares. The firm’s stock price fluctuated -1.98% within the last five trades and -1.06% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price increased 12.35% in the last 6 months and -4.28% was subtracted to its value over the previous 3 months. JNJ stock is trading at a margin of -0.11%, 0.87% and 6.29% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.

As of the close of trading, JNJ deals in the Healthcare domain. The stock is trading -6.03 percent below its 52-week high and 22.10 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is 11.71. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.

What Does Johnson & Johnson’s Profitability and Valuation Ratios Tell Us About the Stock?

With regard to the profitability of the company, the operating margin is currently at 22.60 percent and the profit margin is 20.20 percent, and the company has reported a gross margin of 66.30 percent. The profit margin, also known as the revenue ratio or gross profit ratio, is an efficiency figure used to estimate the business’s profitability by comparing net income and sales. The higher the number, the more profits are generated for the company and vice versa.

The stock’s market cap achieved a total value of $428.72 billion as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. The price-to-earnings ratio for Johnson & Johnson (NYSE:JNJ) is 28.83. The price-to-earnings ratio is a method of assessing corporate values by comparing them to their per-share profit. Forward P/E stands at 15.67. Forward price-to-earnings is calculated using predicted earnings for the next financial year’s P/E determination. The stock has achieved an effective Price-to-Sales Ratio of 5.09 that mirrors the cost to be found for sales by the market. The firm managed a Price-to-Book ratio of 6.79, which equates the market value of a stock with its book value.

Is Insider Trading a Real Thing?

Almost all investors and traders prefer to invest in shares controlled by the management of a corporation as a management company will be more likely to run the business itself and to never conduct things against the management’s desires and will always try to do what is best for their shareholders. Currently, 0.10 percent of Johnson & Johnson shares are owned by insiders, and 69.90 percent are held by financial institutions. Sneed Michael E, the EVP, Global Corp Aff & COO at Johnson & Johnson (JNJ) has sold 54,662 shares of firm on Dec 09 at a price of $152.93 against the total amount of $8.36 million. In another inside trade, Wengel Kathryn E, EVP, Chief GSC Officer of Johnson & Johnson (NYSE:JNJ) sold 16,115 shares of the firm on Sep 02 for a total worth of $2.47 million at a price of $153.52. An inside trade which took place on Jul 28, EVP, WW Chair, Medical Devices of Johnson & Johnson McEvoy Ashley sold 29,000 shares of firm against total price of $4.28 million at the cost of $147.47 per share.

How Johnson & Johnson (JNJ) Stock Is Sustainable?

To Conclude, the score of Environmental, Social and Governance (ESG) has been traditionally used by investors to measure the actions of corporations and to make their future financial predictions. According to the ESG rating scale, there are five hazard levels in the scale: marginal, weak, moderate, high, and extreme. The next generation ESG score is a scale from 0 to 100 where 100 represents the most extreme situation. The score was designed to assist investors at safety and investment level in identifying and recognizing financially relevant ESG threats. A current assessment of the Johnson & Johnson’s sustainability factors indicates that it scores at 59 or 59th percentile overall, with an Environment Score of 1 or 1 percentile, a Social Score of 20 or 20 percentile, and a Governance Score of 10 or 10 percentile.

Leave a Comment

Your email address will not be published. Required fields are marked *

Sign up for our FREE Newsletter and get:
Sign up for our FREE Newsletter and get:

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.